Moderna’s Covid-19 Vaccine Works Safely in Young Children, Company Says

Moderna Inc.’s Covid-19 vaccine safely induced robust immune responses in children ages 6 months to 5 years in a new study, the company said, though the shot had modest efficacy against the Omicron variant. Moderna said Wednesday the vaccine’s efficacy against symptomatic infections was 43.